The global catheter market size was valued at USD 62.45 billion in 2025 and is projected to grow from USD 66.70 billion in 2026 to USD 112.89 billion by 2034, registering a CAGR of 6.8% during the forecast period from 2026 to 2034. North America dominated the catheter market with a market share of 38.4% in 2025.
A catheter is a thin, flexible medical tube inserted into the body to deliver or remove fluids, administer medications, monitor conditions, or perform diagnostic and therapeutic procedures. Catheters are available in various designs and materials depending on their intended use and are commonly used in cardiovascular, urinary, neurological, and other medical applications. They help healthcare professionals perform minimally invasive procedures while supporting effective patient care and treatment.
Download a Free Sample To learn more about this report,
Growing Adoption of Dual-Modality Intravascular Imaging Catheters
The catheter market is advancing toward multifunctional imaging devices that combine complementary visualization technologies within a single catheter. Integrating intravascular ultrasound with high-resolution optical imaging allows physicians to assess both deeper vessel structures and detailed surface characteristics without exchanging separate imaging devices. This can simplify coronary procedures while improving information available for treatment planning. Multi-sensor imaging technology is therefore becoming an important part of catheter market trends.
In October 2025, Terumo received FDA 510(k) clearance for its DualView imaging catheter, which combines OFDI and IVUS imaging. The catheter provides a maximum pullback length of 150 mm, a 2.6 Fr imaging profile, 6 Fr guide compatibility, and pullback speeds reaching 40 mm per second.
Increasing Development of Catheters for Pulsed Field Ablation
Cardiac electrophysiology is increasingly adopting pulsed field ablation, creating demand for specialized catheters capable of delivering controlled electrical fields to cardiac tissue. Unlike conventional thermal ablation, PFA uses short electrical pulses to selectively affect targeted cells, potentially reducing damage to surrounding structures. Catheters that combine mapping and ablation can further simplify electrophysiology workflows. PFA-focused development is consequently expanding the catheter industry toward advanced treatment of cardiac arrhythmias.
In January 2025, Medtronic reported continued commercial expansion of its Sphere-9 catheter with the Affera Mapping and Ablation System. The Sphere-9 integrates high-density mapping with both pulsed-field and radiofrequency ablation through a single 9 mm lattice-tip catheter.
Growing Need for Advanced Atrial Fibrillation Treatment
Atrial fibrillation is increasing the requirement for catheter-based procedures capable of identifying and treating abnormal electrical pathways within the heart. Modern ablation catheters provide greater control over energy delivery and tissue contact, helping physicians perform increasingly sophisticated electrophysiology procedures. As catheter ablation becomes more widely used for rhythm management, demand for specialized devices continues to increase. Expansion of interventional arrhythmia treatment is therefore strengthening catheter market demand.
In May 2025, Abbott launched its TactiFlex Sensor Enabled ablation catheter, combining a flexible electrode tip with contact-force sensing. Clinical evidence associated with the technology showed procedure times averaging approximately 59 minutes, supporting more efficient catheter-based atrial fibrillation treatment.
Complex Regulatory Requirements Increase Product Development Burden
Catheters used in invasive cardiovascular, neurovascular, and other procedures must undergo extensive design validation, biocompatibility assessment, sterilization testing, performance evaluation, and regulatory review. Manufacturers must demonstrate that new devices are sufficiently safe and effective before commercialization, while design modifications may trigger additional regulatory requirements. These processes increase development costs and can delay market entry. Regulatory complexity can consequently restrain catheter market growth, particularly for smaller manufacturers developing specialized devices.
In April 2025, Teleflex reported that the FDA 510(k) clearance pathway for eligible medical devices generally requires approximately 4–9 months and can take longer, demonstrating the regulatory time requirements facing manufacturers introducing new catheter-based and other interventional technologies.
Expansion of Catheter-Based Treatment for Calcified Coronary Arteries
Severely calcified coronary lesions create an opportunity for specialized catheters that modify calcium before angioplasty or stent implantation. Intravascular lithotripsy delivers mechanical energy through a catheter to fracture calcium while limiting trauma to surrounding soft tissue. Increasing treatment of complex coronary disease can therefore expand demand for dedicated lesion-preparation devices. This application provides manufacturers with an opportunity to increase catheter market share through advanced coronary interventions.
In May 2026, Boston Scientific reported results from the FRACTURE IDE trial of its SEISMIQ 4CE coronary intravascular lithotripsy catheter. The study enrolled 399 patients with severely calcified coronary lesions and achieved 93.8% procedural success.
Maintaining Reliable Central Venous Access in Patients With Venous Obstruction
Repeated dialysis, chemotherapy, and other long-term therapies can cause central veins to narrow or become obstructed, making conventional catheter placement increasingly difficult. Clinicians must establish vascular access while avoiding complications and preserving remaining veins for future treatment. Specialized access systems therefore need sufficient navigation capability and procedural control to cross challenging anatomy safely. Managing complex venous obstruction remains a significant technical challenge as catheter market size expands across patients requiring repeated vascular access.
In September 2025, Merit Medical received expanded FDA 510(k) clearance for its Surfacer Inside-Out Access Catheter System. The system is designed to establish central venous access in patients with upper-body venous obstruction and is available in working lengths of 95 cm and 105 cm.
Cardiovascular Catheters Segment Dominated the Market with 42.7% Share in 2025
The cardiovascular catheters segment dominated the global catheter market with a 42.7% market share in 2025, valued at USD 26.67 billion. The segment's leadership is supported by the widespread use of catheters in cardiovascular diagnosis and treatment, including angiography, angioplasty, electrophysiology, cardiac monitoring, and minimally invasive interventions. Growing preference for catheter-based procedures that can reduce surgical trauma and recovery time continues to strengthen their role in cardiovascular care.
Urology catheters, specialty catheters, and other product categories continue to support market demand across a broad range of medical procedures. Improvements in catheter materials, coatings, flexibility, navigation, and infection-prevention features are helping manufacturers address different clinical requirements while improving procedural efficiency and patient comfort.
Request Customizationto receive a tailored report.
Ambulatory Surgical Centres Segment is Projected to Register the Fastest Growth at a CAGR of 8.84%
The ambulatory surgical centers segment is projected to register the fastest growth at a CAGR of 8.84% during the forecast period. The growing shift of suitable minimally invasive procedures from traditional inpatient environments to outpatient surgical facilities is supporting catheter utilization in these centers. Shorter patient stays, streamlined procedural workflows, and advancements in catheter-based interventions are enabling a broader range of procedures to be performed in ambulatory settings.
Hospitals, clinics, and other healthcare facilities remain important users of catheter products due to their extensive role in diagnostic, therapeutic, surgical, and patient-management procedures. Continued improvements in healthcare infrastructure and growing adoption of minimally invasive treatment approaches are supporting catheter usage across these settings.
Speak to an Analystto discuss market opportunities.
The North American catheter market accounted for 38.4% of the global market, reaching USD 23.98 billion in 2025, and is projected to grow at a CAGR of 7.62% during the forecast period. Market growth is driven by the high prevalence of cardiovascular, urological, and chronic diseases, increasing surgical procedures, growing demand for minimally invasive interventions, advanced healthcare infrastructure, and rising adoption of technologically advanced catheter products.
The United States represents the largest market in North America. Advanced healthcare infrastructure, high volume of surgical and interventional procedures, increasing prevalence of chronic diseases, and strong adoption of minimally invasive medical technologies continue to support catheter market growth.
Canada's established healthcare infrastructure, increasing demand for minimally invasive procedures, aging population, and rising prevalence of chronic and cardiovascular conditions continue to support steady market development.
Unlock Regional Insightsto access country-level data, & regional trends.
The European catheter market accounted for 28.1% of the global market, reaching USD 17.55 billion in 2025, and is expected to register a CAGR of 9.28% during the forecast period. Europe records the fastest growth among the listed regions, supported by an aging population, increasing surgical volumes, rising adoption of minimally invasive procedures, growing healthcare expenditure, and continued development of advanced catheter technologies.
Germany represents a major European market. Its advanced healthcare infrastructure, large patient population requiring cardiovascular and urological interventions, and increasing adoption of minimally invasive medical devices continue to support market expansion.
The United Kingdom's focus on improving minimally invasive care, increasing demand for advanced medical devices, and rising prevalence of chronic and cardiovascular diseases continue to strengthen catheter market development.
The Asia Pacific catheter market accounted for 22.6% of the global market, reaching USD 14.11 billion in 2025, and is projected to grow at a CAGR of 8.74% during the forecast period. Increasing healthcare expenditure, expanding hospital infrastructure, rising prevalence of chronic diseases, growing surgical volumes, and increasing adoption of minimally invasive interventions continue to drive regional market growth.
China represents a major market within the Asia Pacific. Expanding healthcare infrastructure, increasing cardiovascular and urological procedures, growing healthcare expenditure, and rising adoption of minimally invasive technologies continue to support catheter market growth.
India's expanding healthcare infrastructure, increasing availability of advanced medical facilities, rising surgical volumes, and growing prevalence of cardiovascular and chronic diseases continue to strengthen demand for catheter-based interventions.
Japan's aging population, sophisticated healthcare system, high prevalence of cardiovascular conditions, and increasing adoption of minimally invasive procedures continue to support catheter market development.
The Latin America catheter market accounted for 6.3% of the global market, reaching USD 3.93 billion in 2025, and is expected to grow at a CAGR of 7.31% during the forecast period. Increasing healthcare investments, expanding hospital infrastructure, growing demand for minimally invasive procedures, and rising prevalence of chronic and cardiovascular diseases continue to support regional market development.
Brazil represents a major regional market. Expanding healthcare services, increasing cardiovascular procedures, growing demand for minimally invasive treatments, and development of advanced hospital facilities continue to create opportunities for catheter manufacturers.
The Middle East & Africa catheter market accounted for 4.6% of the global market, reaching USD 2.87 billion in 2025, and is anticipated to grow at a CAGR of 6.95% during the forecast period. Increasing healthcare infrastructure investments, expanding access to specialized medical care, rising surgical procedures, and growing adoption of minimally invasive technologies continue to support regional market expansion.
The UAE's advanced healthcare infrastructure, increasing investment in specialized hospitals, growing medical tourism, and rising adoption of minimally invasive procedures continue to support demand for catheter products.
Saudi Arabia's healthcare infrastructure expansion, increasing investments in advanced medical facilities, rising prevalence of chronic diseases, and growing adoption of interventional and minimally invasive procedures continue to strengthen catheter market development.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, competitive dynamics, and market opportunities. Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.
Breast Implants Market Size, Share, Growth, Analysis, 2034
Continuous Glucose Monitoring Systems Market Size, Share, 2034
Colposcopes Market Size, Share, Growth, Analysis, Report, 2034
Alpha Emitter Market Size, Share, Growth, Analysis, Report, 2034
Bioabsorbable Stents Market Size, Share, Growth, Analysis, 2034
Artificial Cornea and Corneal Implant Market Size, Share, 2034
We are featured on:
sales@straitsresearch.com